Incremental high power radiofrequency ablation with multi-electrodes for small hepatocellular carcinoma: a prospective study
BMC Gastroenterology · 2024
DOI: 10.1186/s12876-024-03358-w ↗Kurz gefasst
Klinische Studie in der Zeitschrift BMC Gastroenterology, 2024. Verfasst von Sungjun Hwang und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Neoplasm Recurrence, Local, Radiofrequency Ablation. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Starmed.
Abstract (Originalsprache)
Radiofrequency ablation (RFA) offers a minimally invasive treatment for small hepatocellular carcinoma (HCC), but it faces challenges such as high local recurrence rates. This prospective study, conducted from January 2020 to July 2022, evaluated a novel approach using a three-channel, dual radiofrequency (RF) generator with separable clustered electrodes to improve RFA’s efficacy and safety. The study employed a high-power, gradual, stepwise RFA method on HCCs (≤ 4 cm), utilizing real-time ultrasound-computed tomography (CT)/magnetic resonance imaging (MRI) fusion imaging. Involving 110 participants with 116 HCCs, the study reported no major complications. Local tumor progression (LTP) and intrahepatic remote recurrence (IRR) rates were low, with promising cumulative incidences at 1, 2, and 3 years for LTP (0.9%, 3.6%, 7.0%) and IRR (13.9%, 20.5%, 31.4%). Recurrence-free survival (RFS) rates were similarly encouraging: LTP (99.1%, 96.4%, 93.0%) and IRR (86.1%, 79.5%, 68.6%). This innovative gradual, incremental high-power RFA technique, featuring a dual switching monopolar mode and three electrodes, represents an effective and safer management option for small HCCs. Trial registration clinicaltrial.gov identifier: NCT05397860, first registered on 26/05/2022.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Inje University Ilsan Paik Hospital, Goyang, Republic of Korea.
- Department of Radiology, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, Republic of Korea.
- Department of Internal Medicine and Liver Research Institute, College of Medicine, Seoul National University, Seoul, Republic of Korea.
- Department of Radiology, Seoul National University Hospital, 101, Daehak-ro, Jongno-gu, Seoul, Republic of Korea. jmsh@snu.ac.kr.
- Institute of Radiation Medicine, Seoul National University Medical Research Center, Seoul, Republic of Korea. jmsh@snu.ac.kr.
- Department of Radiology, Seoul National University College of Medicine, Seoul, Republic of Korea. jmsh@snu.ac.kr.
ORCID-Profile: Sungjun Hwang, Jae Hyun Kim, Su Jong Yu, Jeong Min Lee
Förderung
- Starmed
Zitieren
APA
Hwang, S., Kim, J. H., Yu, S. J., & Lee, J. M. (2024). Incremental high power radiofrequency ablation with multi-electrodes for small hepatocellular carcinoma: a prospective study. BMC Gastroenterology. https://doi.org/10.1186/s12876-024-03358-w
Vancouver
Hwang S, Kim JH, Yu SJ, Lee JM. Incremental high power radiofrequency ablation with multi-electrodes for small hepatocellular carcinoma: a prospective study. BMC Gastroenterology. 2024. doi:10.1186/s12876-024-03358-w
BibTeX
@article{Hwang2024,
author = {Hwang, Sungjun and Kim, Jae Hyun and Yu, Su Jong and Lee, Jeong Min},
title = {Incremental high power radiofrequency ablation with multi-electrodes for small hepatocellular carcinoma: a prospective study},
journal = {BMC Gastroenterology},
year = {2024},
doi = {10.1186/s12876-024-03358-w}
}
EUVIMED